Cargando…
Cell Type-Specific Interferon-γ-mediated Antagonism of KSHV Lytic Replication
Kaposi’s sarcoma-associated herpesvirus (KSHV) is causally associated with several malignant tumors: Kaposi’s sarcoma (KS), multicentric Castleman’s disease (MCD), and primary effusion lymphoma (PEL). KS remains the most common AIDS-related malignancy since the AIDS epidemic and thus has been extens...
Autores principales: | Park, Mi-Kyung, Cho, Hyejeong, Roh, Seong Woon, Kim, Seong-Jun, Myoung, Jinjong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6382833/ https://www.ncbi.nlm.nih.gov/pubmed/30787356 http://dx.doi.org/10.1038/s41598-019-38870-7 |
Ejemplares similares
-
RSK1 SUMOylation is required for KSHV lytic replication
por: Liu, Zhenshan, et al.
Publicado: (2021) -
KSHV Targeted Therapy: An Update on Inhibitors of Viral Lytic Replication
por: Coen, Natacha, et al.
Publicado: (2014) -
Activation of DNA Damage Response Pathways during Lytic Replication of KSHV
por: Hollingworth, Robert, et al.
Publicado: (2015) -
Molecular Biology of KSHV Lytic Reactivation
por: Purushothaman, Pravinkumar, et al.
Publicado: (2015) -
Regulation of KSHV Latency and Lytic Reactivation
por: Broussard, Grant, et al.
Publicado: (2020)